Zobrazeno 1 - 10
of 23
pro vyhledávání: '"I. A. Hauser"'
Autor:
I. A. Hauser, H.-N. Neumayer, A. D. Mayer, J. Dmitrewski, J.-P. Squifflet, T. Besse, B. Grabensee, B. Klein, F. W. Eigler, U. Heemann, R. Pichlmayr, M. Behrend, Y. Vanrenterghem, J. Donck, J. van Hooff, M. Christiaans, J. M. Morales, A. Andres, R. W. G. Johnson, C. Short, B. Buchholz, N. Rehmert, W. Land, S. Schleibner, J. L. R. Forsythe, D. Talbot, B.-G. Ericzon, C. Brattström, K. Claesson, F. Mühlbacher, E. Pohanka
Publikováno v:
Transplant International. 11:S73-S77
The efficacy and safety of tacrolimus- and cyclosporine-based immunosuppressive regimens were compared in a prospectively defined subgroup of kidney transplant recipients from the European, open, multicentre, 2:1 randomised, parallel group study. Pat
Publikováno v:
The Journal of Immunology. 151:5172-5185
Venous and arterial large vessel endothelial cells (EC) were compared for their constitutive and TNF-alpha-induced expression of the cell-surface adhesion molecules ICAM-1 and -2, VCAM-1 and ELAM-1 by FACS analysis. Human iliac venous and arterial EC
Autor:
Wassilios, Bentas, M, Probst, J, Jones, A, Karaoguz, I, Cerovac, E, Scheuermann, I A, Hauser, D, Jonas, J, Gossmann
Publikováno v:
Der Urologe. Ausg. A. 46(3)
Organ damage during organ procurement is believed to be an increasing problem among transplant centres. However, only very few published data are available. The purpose of our study was to examine the quality of kidney procurement in Germany.We retro
Autor:
S, Barlage, I A, Hauser, R, Elbracht, C, Abletshauser, R E, Schmieder, G, Weidinger, K J, Lackner, G, Rothe, G, Schmitz
Publikováno v:
Journal of biological regulators and homeostatic agents. 19(3-4)
Flow cytometric T-cell analysis is capable of adding valuable information for balancing immunosuppression in transplant recipients as it can take into account individual effects of immunosuppressive drugs on each patient as well as effects of other d
Publikováno v:
Clinical nephrology. 58(1)
Background: Autosomal dominant polycystic kidney disease (ADPKD) as a systemic disorder represents a special subgroup among patients with end-stage renal disease (ESRD). The different organ manifestations are potential risk factors for cardiovascular
Autor:
R, Wassmuth, I A, Hauser, K, Schuler, H, Erxleben, M L, Arnold, C A, Koelman, F H, Claas, J R, Kalden
Publikováno v:
Transplantation. 71(10)
Treatment of allosensitized patients with intravenously administered pooled immunoglobulin preparations (IVIG) may lead to a long-lasting reduction of anti-HLA alloantibody titers. An inhibitory response of IVIG preparations on lymphocytotoxicity is
Autor:
I A, Hauser, G G, Persijn
Publikováno v:
Kidneyblood pressure research. 23(3-5)
Autor:
H H, Neumayer, K, Paradis, A, Korn, C, Jean, L, Fritsche, K, Budde, M, Winkler, V, Kliem, R, Pichlmayr, I A, Hauser, K, Burkhardt, A E, Lison, I, Barndt, S, Appel-Dingemanse
Publikováno v:
British journal of clinical pharmacology. 48(5)
To evaluate the tolerability of single oral SDZ RAD doses in stable renal transplant recipients and the pharmacokinetics of ascending SDZ RAD doses when coadministered with steady-state cyclosporin A microemulsion (Neoral).This randomized, double-bli
Autor:
I A, Hauser, H N, Neumayer
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 11
The efficacy and safety of tacrolimus- and cyclosporine-based immunosuppressive regimens were compared in a prospectively defined subgroup of kidney transplant recipients from the European, open, multicentre, 2:1 randomised, parallel group study. Pat